Rany Aburashed
Neurology · Owosso, MINPI 1790909711
Payments from drug & device makers
Across 843 payments — averaging $2257.31 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sanofi$584K
- AbbVie$584K
- Biogen$231K
- Novartis$141K
- Genentech, Inc.$82K
- Janssen Research & Development, LLC$58K
- plus $223K from 31 others
Across 23 payments — averaging $426.94 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Novartis$5K
- Sanofi$4K
- AbbVie$618
What the payments were for
- Consulting fees$93,80221%
- Speaking & faculty fees$251,80457%
- Travel & lodging$37,7309%
- Food & beverage$8,7842%
- Education$1310%
- Other$48,16811%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sanofi | 376 | $584,197 |
| AbbVie(2 entities) | 92 | $584,158 |
| Biogen | 75 | $231,088 |
| Novartis | 84 | $140,746 |
| Genentech, Inc. | 17 | $82,185 |
| Janssen Research & Development, LLC | 19 | $57,912 |
| Genentech USA, Inc. | 47 | $53,794 |
| Medtronic | 1 | $48,168 |
| Sanofi-aventis U.S. LLC | 13 | $41,273 |
| EMD Serono, Inc. | 39 | $28,736 |
| Bristol Myers Squibb | 23 | $26,652 |
| E.r. Squibb & Sons, L.L.C. | 6 | $8,229 |
| F. Hoffmann-la Roche AG | 1 | $6,000 |
| Mallinckrodt Hospital Products Inc. | 1 | $3,575 |
| Johnson & Johnson | 2 | $2,625 |
| Sanofi US Services Inc. | 3 | $1,083 |
| TG Therapeutics, Inc. | 3 | $905 |
| Intuitive Surgical | 2 | $729 |
| Grifols USA, LLC | 7 | $184 |
| Bard Peripheral Vascular, Inc. | 1 | $100 |
| Teva Pharmaceuticals USA, Inc. | 5 | $73 |
| Amgen | 3 | $61 |
| UCB, Inc. | 3 | $57 |
| Acorda Therapeutics, Inc | 2 | $42 |
| AstraZeneca | 2 | $41 |
| Acadia Pharmaceuticals Inc | 2 | $40 |
| Supernus Pharmaceuticals, Inc. | 2 | $40 |
| Nevro Corp. | 1 | $35 |
| Avanir Pharmaceuticals, Inc. | 2 | $30 |
| Alnylam Pharmaceuticals Inc. | 1 | $27 |
| Catalyst Pharmaceuticals, Inc. | 1 | $23 |
| Lilly USA, LLC | 2 | $23 |
| Scilex Pharmaceuticals Inc. | 1 | $20 |
| Kyowa Kirin, Inc. | 1 | $18 |
| Harmony Biosciences LLC | 1 | $17 |
| Neurocrine Biosciences, Inc. | 1 | $16 |
| Eisai Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,902,914 in reported general payments places this provider in the 95th percentile of 652 neurology providers in Michigan.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| ZtlidoLidocaine | 31 | $29,673 |
| RelistorMethylnaltrexone Bromide | 33 | $26,955 |
| GraliseGabapentin | 40 | $12,673 |
| Diclofenac Sodium | 31 | $10,287 |
| Carbidopa-LevodopaCarbidopa/Levodopa | 20 | $686 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Scilex Pharmaceuticals Inc.Ztlido | $20 | $29,67331 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 652 neurology providers in Michigan.
Other neurology in Owosso
- Jeanie CoteOwosso$1.8M
- Robert PaceOwosso$1M
- Rosemarie WalchOwosso$757K
- Margaret FreyOwosso$540K
- Cara LeahyOwosso$214K
- Aaron EllenbogenFarmington Hills$14.5M
- Martin BelkinFarmington Hills$5.8M
- Evanthia BernitsasDetroit$4.8M
- Yang Mao DraayerFarmington Hills$4.2M
- Mirela CerghetDetroit$3.8M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.